ES8500273A1 - Un procedimiento para preparar pirazolo (4,3-c)piridinas. - Google Patents

Un procedimiento para preparar pirazolo (4,3-c)piridinas.

Info

Publication number
ES8500273A1
ES8500273A1 ES519832A ES519832A ES8500273A1 ES 8500273 A1 ES8500273 A1 ES 8500273A1 ES 519832 A ES519832 A ES 519832A ES 519832 A ES519832 A ES 519832A ES 8500273 A1 ES8500273 A1 ES 8500273A1
Authority
ES
Spain
Prior art keywords
formula
pyridines
pharmacologically active
temperature
active pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519832A
Other languages
English (en)
Spanish (es)
Other versions
ES519832A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES519832A0 publication Critical patent/ES519832A0/es
Publication of ES8500273A1 publication Critical patent/ES8500273A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES519832A 1982-02-17 1983-02-16 Un procedimiento para preparar pirazolo (4,3-c)piridinas. Expired ES8500273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8204722 1982-02-17

Publications (2)

Publication Number Publication Date
ES519832A0 ES519832A0 (es) 1984-10-01
ES8500273A1 true ES8500273A1 (es) 1984-10-01

Family

ID=10528419

Family Applications (3)

Application Number Title Priority Date Filing Date
ES519832A Expired ES8500273A1 (es) 1982-02-17 1983-02-16 Un procedimiento para preparar pirazolo (4,3-c)piridinas.
ES531980A Granted ES531980A0 (es) 1982-02-17 1984-04-27 Un procedimiento para preparar pirazolo (4,3-c) piridinas
ES531981A Granted ES531981A0 (es) 1982-02-17 1984-04-27 Un procedimiento para preparar pirazolo (4,3-c) piridinas

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES531980A Granted ES531980A0 (es) 1982-02-17 1984-04-27 Un procedimiento para preparar pirazolo (4,3-c) piridinas
ES531981A Granted ES531981A0 (es) 1982-02-17 1984-04-27 Un procedimiento para preparar pirazolo (4,3-c) piridinas

Country Status (16)

Country Link
US (1) US4500525A (enExample)
EP (1) EP0086422B1 (enExample)
JP (1) JPS58152885A (enExample)
KR (1) KR900006853B1 (enExample)
AT (1) ATE30027T1 (enExample)
AU (1) AU563591B2 (enExample)
CA (1) CA1225646A (enExample)
DE (1) DE3373904D1 (enExample)
DK (1) DK27383A (enExample)
ES (3) ES8500273A1 (enExample)
GR (1) GR78080B (enExample)
IE (1) IE55156B1 (enExample)
IL (1) IL67785A0 (enExample)
NZ (1) NZ203302A (enExample)
PH (1) PH23645A (enExample)
ZA (1) ZA83628B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5264576A (en) * 1992-10-22 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazolo[4,3-c]pyridines which are intermediates
DE19834044A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
DK1309591T3 (da) * 2000-08-14 2007-03-26 Ortho Mcneil Pharm Inc Substituerede pyrazoler
US20050101587A9 (en) * 2000-08-14 2005-05-12 Butler Christopher R. Method for treating allergies using substituted pyrazoles
US20070117785A1 (en) * 2000-08-14 2007-05-24 Butler Christopher R Substituted pyrazoles and methods of treatment with substituted pyrazoles
CA2419550A1 (en) 2000-08-14 2002-02-21 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
ES2261463T3 (es) 2000-08-14 2006-11-16 Ortho-Mcneil Pharmaceutical, Inc. Pirazoles sustituidos.
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
HK1053129A1 (zh) 2000-09-06 2003-10-10 Ortho-Mcneil Pharmaceutical, Inc. 治疗变态反应的方法
CA2421505A1 (en) * 2000-09-06 2002-03-14 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies using substituted pyrazoles
RU2286343C2 (ru) * 2001-08-10 2006-10-27 Орто-Макнейл Фармасьютикал, Инк. Замещенные пиразолы
EP1507779A1 (en) * 2002-05-30 2005-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of jak and cdk2 protein kinases
US20060100233A1 (en) * 2002-07-25 2006-05-11 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2243781A1 (en) * 2003-05-30 2010-10-27 Vertex Pharmaceuticals, Inc. Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
KR101151653B1 (ko) 2003-09-17 2012-06-28 얀센 파마슈티카 엔.브이. 융합된 헤테로사이클릭 화합물
WO2005030776A1 (en) 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Pyrazolopyrrole derivatives as protein kinase inhibitors
KR100838692B1 (ko) 2007-07-11 2008-06-16 한국화학연구원 7-(3′,4′-디알콕시페닐)-4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 화합물, 이의 제조방법 및 이를 포함하는천식 및 만성폐쇄성 폐질환을 포함한 염증관련 질환,관절염, 아토피 피부염, 암 및 뇌질환의 치료 및 예방을위한 약제학적 조성물
US9242981B2 (en) 2010-09-16 2016-01-26 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel ERK inhibitors
EP2755972B1 (en) 2011-09-12 2015-10-28 Sanofi Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
MX2014002968A (es) 2011-09-12 2014-07-09 Sanofi Sa 4,5,6,7 - tetrahidro - 1h - pirazolo [4,3 -c] piridinas sustituidas con indanilo, su uso como medicamento, y preparaciones farmaceuticas que las comprenden.
PT2755973E (pt) 2011-09-16 2016-02-16 Sanofi Sa Piridinas 4,5,6,7-tetra-hidro-1h-pirazolo[4,3-c]substituídas e sua utilização como medicamentos e preparados farmacêuticos que as contenham
BR112014006180A2 (pt) 2011-09-16 2017-04-11 Sanofi Sa 4, 5, 6, 7-tetraidro-1h-pirazol [4, 3-c] piridinas substituídas, seu uso como medicamento e preparações farmacêuticas que compreendem as mesmas
CN107531691A (zh) 2014-12-30 2018-01-02 诺维拉治疗公司 治疗乙型肝炎感染的衍生物和方法
CN109476663B (zh) * 2016-05-24 2021-11-09 基因泰克公司 用于治疗癌症的吡唑并吡啶衍生物
TW201806956A (zh) 2016-06-29 2018-03-01 諾維拉治療公司 二氮呯酮衍生物及治療ｂ型肝炎感染之方法
US10975077B2 (en) 2016-06-29 2021-04-13 Novira Therapeutics, Inc. Diazepinone derivatives and their use in the treatment of hepatitis B infections
MX392259B (es) 2017-05-31 2025-03-24 Chemocentryx Inc ANILLOS 6-5 FUSIONADOS COMO INHIBIDORES C5a
US10828285B2 (en) * 2017-12-22 2020-11-10 Chemocentryx, Inc. Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852279A (en) * 1973-03-12 1974-12-03 Squibb & Sons Inc 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines

Also Published As

Publication number Publication date
KR840003636A (ko) 1984-09-15
IE55156B1 (en) 1990-06-20
ES8507546A1 (es) 1985-09-01
AU563591B2 (en) 1987-07-16
ATE30027T1 (de) 1987-10-15
DE3373904D1 (en) 1987-11-05
KR900006853B1 (ko) 1990-09-22
AU1130583A (en) 1983-08-25
ES531980A0 (es) 1985-09-01
ZA83628B (en) 1983-12-28
EP0086422B1 (en) 1987-09-30
PH23645A (en) 1989-09-27
EP0086422A2 (en) 1983-08-24
US4500525A (en) 1985-02-19
IL67785A0 (en) 1983-05-15
ES8507547A1 (es) 1985-09-01
JPS58152885A (ja) 1983-09-10
ES519832A0 (es) 1984-10-01
DK27383D0 (da) 1983-01-25
NZ203302A (en) 1986-08-08
IE830328L (en) 1983-08-17
JPH0412269B2 (enExample) 1992-03-04
DK27383A (da) 1983-08-18
CA1225646A (en) 1987-08-18
ES531981A0 (es) 1985-09-01
EP0086422A3 (en) 1984-03-28
GR78080B (enExample) 1984-09-26

Similar Documents

Publication Publication Date Title
ES8500273A1 (es) Un procedimiento para preparar pirazolo (4,3-c)piridinas.
ES8303293A1 (es) "procedimiento de preparar derivados carboxamidicos".
ES8608874A1 (es) Un procedimiento para la preparacion de una 2-(1h)-quinolona
ES8407049A1 (es) Un procedimiento para la preparacion de compuestos biciclicos.
ES8307749A1 (es) Un procedimiento para la preparacion de inhibidores biciclicos de tromboxano sintetasa
ES8801655A1 (es) Un procedimiento para preparar derivados de piridina
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8704946A1 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8600211A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenilicos
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES8206527A1 (es) Procedimiento para la 5-aroilacion de esteres de acidos 1,2-dihidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos.
ES8708225A1 (es) Procedimiento para preparar nuevos compuestos de benzotiofe-no y benzofurano
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ES8307202A1 (es) "procedimiento para preparar un acido alcanoico substituido en posicion alfa con un grupo aromatico, opticamente activo".
ES8202015A1 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES8303404A1 (es) Procedimiento para preparar 3-amino-sidnoniminas sustituidas.
ES8401034A1 (es) Derivados de quinolina.
ES8205791A1 (es) Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
ES8403461A1 (es) Procedimiento de preparacion de derivados de imidazolidina.
ES8300332A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas
ES8504189A1 (es) Un compuesto de pirazol (3,4-b) piridina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303